Stock A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Chong Kun Dang Pharmaceutical Corp.

Equities

A185750

KR7185750007

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
110,600 KRW +3.46% Intraday chart for Chong Kun Dang Pharmaceutical Corp. +10.49% -15.51%
Apr. 25 Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024. CI
Jan. 23 Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares. CI

Chart calendar Chong Kun Dang Pharmaceutical Corp.

416826e0aa6bf66182bdba.9c8MXoyKE7DBjMDrKfxaAQPHxPyH4Ql2p01mEGuaxfU.kPY8B_7BWMCJ46eseMUqQGGFtLjt2VM87isieBGrvLaPt1o_1v4ggPn2sw~bdf61e7d37502e476fd43c6227467905

Upcoming events on Chong Kun Dang Pharmaceutical Corp.

2024-08-12 Q2 2024 Earnings Release (Projected)
2025-04-06 Q4 2024 Earnings Release (Projected)
2025-05-18 Q1 2025 Earnings Release (Projected)
2026-05-17 Q1 2026 Earnings Release (Projected)

Past events on Chong Kun Dang Pharmaceutical Corp.

2024-05-15 Q1 2024 Earnings Release
2024-03-19 Q4 2023 Earnings Release
2023-05-14 Q1 2023 Earnings Release
2023-03-13 Q4 2022 Earnings Release
2022-08-15 Interim 2022 Earnings Release
2022-05-15 Q1 2022 Earnings Release
2021-08-16 Interim 2021 Earnings Release
2021-05-16 Q1 2021 Earnings Release
2021-02-07 FY 2020 Earnings Release
2020-03-29 FY 2019 Earnings Release
2019-11-13 Q3 2019 Earnings Release
2019-05-14 Q1 2019 Earnings Release
2018-07-25 Interim 2018 Earnings Release
2017-04-23 Q1 2017 Earnings Release

Past dividends on Chong Kun Dang Pharmaceutical Corp.

2023-12-26 Annual 1100 KRW
2022-12-27 Annual 1000 KRW
2021-12-28 Annual 1000 KRW
2020-12-28 Annual 1000 KRW
2019-12-26 Annual 900 KRW
2018-12-26 Annual 900 KRW
2017-12-26 Annual 900 KRW
2016-12-27 Annual 900 KRW
2015-12-28 Annual 600 KRW
2014-12-28 Annual 800 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		1 079
1 070
0.85%		1 301
1 310
-0.72%		1 334
1 337
-0.24%		1 472
1 463
0.61%		1 650
1 633
1.01%
1 541

EBITDA
Billions KRW		Released
Forecast
Spread 		94,8
95,2
-0.5%		145
161
-9.83%		119
137
-12.77%		138
141
-2.37%		276
260
6.29%
149

EBIT
Billions KRW		Released
Forecast
Spread 		77,0
74,5
3.42%		127
139
-8.61%		94,1
113
-16.67%		107
111
-3.93%		241
226
6.53%
115

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		72,7
70,7
2.9%		120
134
-10.43%		77,4
95,2
-18.7%		101
108
-6.21%		237
229
3.26%
118

Net income
Billions KRW		Released
Forecast
Spread 		53,9
50,3
7.04%		88,7
100
-11.61%		39,4
53,4
-26.14%		82,9
85,2
-2.63%		209
201
4.03%
96,2

EPS
KRW		Released
Forecast
Spread 		4 300
3 800
13.17%		7 082
7 579
-6.56%		3 168
4 098
-22.68%		6 771
6 443
5.1%		16 416
15 391
6.66%
7 156

Announcement Date31/01/2008/02/2110/02/2203/02/2305/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Billions KRW		Released
Forecast
Spread 		338
335
0.95%		365
352
3.73%		381
371
2.6%		389
379
2.49%		360
357
0.88%		392
378
3.63%		396
397
-0.26%		501
504
-0.49%		353
355
-0.47%
388


397


388


391


415

EBITDA
Billions KRW		Released
Forecast
Spread




















123
121
1.67%		36,0
33,8
6.71%
42,8


44,0


28,5


40,1


46,4

EBIT
Billions KRW		Released
Forecast
Spread 		24,3
22,7
7.41%		28,1
26,1
7.75%		39,7
35,8
10.78%		15,0
18,2
-17.31%		30,1
29,0
3.66%		43,4
34,0
27.72%		53,1
48,1
10.34%		114
116
-1.69%		26,8
25,4
5.26%
32,4


34,3


21,8


31,0


38,6

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		23,6
17,0
38.88%		26,0
20,8
25.37%		37,7
35,9
4.98%		13,6
21,6
-37.11%		30,3
28,0
8.24%		43,3
33,3
29.89%		52,6
45,9
14.65%		111
115
-4.05%		31,8
25,3
25.51%
29,3


33,1


21,2


28,0


39,0

Net income
Billions KRW		Released
Forecast
Spread 		17,2
15,8
8.78%		24,5
17,2
42.18%		29,2
24,8
17.94%		12,1
12,7
-4.6%		34,9
22,0
58.58%		41,8
25,9
61.67%		43,5
39,3
10.86%		88,6
93,4
-5.09%		25,1
21,0
19.37%
30,0


31,0


11,0


22,0


31,0

Announcement Date29/04/2229/07/2228/10/2203/02/2315/05/2328/07/2327/10/2305/02/2426/04/24-----

Upcoming sector events for Chong Kun Dang Pharmaceutical Corp.

2024-07-18 02:15 am KRKA, D. D.: Q2 2024 Earnings Release
2024-07-24 AJANTA PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 SANOFI INDIA LIMITED: Q2 2025 Earnings Release
2024-07-25 BORYUNG CORPORATION: Q2 2024 Earnings Release (Projected)
2024-07-25 CIPLA LIMITED: Q1 2025 Earnings Release
2024-07-29 SANOFI INDIA LIMITED: Q2 2024 Earnings Release (Projected)
2024-07-30 STRIDES PHARMA SCIENCE LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-30 OTSUKA HOLDINGS CO., LTD.: Q2 2024 Earnings Release
2024-07-30 ONO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-07-31 ZERIA PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
More events

Past sector events for Chong Kun Dang Pharmaceutical Corp.

2024-05-28 11:53 am WOCKHARDT LIMITED: Q4 2024 Earnings Release
2024-05-24 10:54 am GLENMARK PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-22 05:35 am SUN PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release
2024-05-22 04:13 am STRIDES PHARMA SCIENCE LIMITED: Q4 2024 Earnings Release
2024-05-19 02:46 am MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY: Q1 2024 Earnings Release
2024-05-17 06:10 am ZYDUS LIFESCIENCES LIMITED: Q4 2024 Earnings Release
2024-05-16 04:25 am CAPLIN POINT LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-16 02:15 am KRKA, D. D.: Q1 2024 Earnings Release
2024-05-15 SAM CHUN DANG PHARM. CO., LTD: Q1 2024 Earnings Release
2024-05-15 CELLTRION PHARM, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A185750 Stock
  4. Calendar Chong Kun Dang Pharmaceutical Corp.